US regulators to decide on ‘female Viagra’
An advisory panel to the Food and Drug Administration urged regulators to approve the drug, flibanserin, after previously voting against it twice in years past
© AFP/File Miguel Medina
Washington (AFP) – US regulators are expected to decide Tuesday whether to approve a drug nicknamed the “female buy viagra online,” which would be the first pill on the market to raise women’s sex drive.
In June, an advisory panel to the Food and Drug Administration urged regulators to approve the drug, flibanserin, after previously voting against it twice in years past.
This time, the experts voted 18-6 in favor of allowing the drug on the market, but with some additional risk-control measures to make sure doctors prescribe it only to patients who need it and that women are aware of the risks.
The FDA is not required to follow the advice of the panel, but it often does.
A spokeswoman for Sprout Pharmaceuticals in North Carolina told AFP that the FDA decision was expected Tuesday but was unsure what time. An FDA spokeswoman declined to comment.